Page 312 - ACCCN's Critical Care Nursing

Cardiac Rhythm Assessment and Management 289

38 Nolan, JP, Soar J, Zideman DA et al on behalf of the ERC Guidelines Writing syndrome treated with an AAI/AAIR pacemaker. Pacing Clin Electrophysiology
Group. European Resuscitation Council Guidelines for Resuscitation 2010. 2001; 24: 358–65.
Section 1. Resuscitation 2010; 81: 1219–76. 65. Brandt J, Anderson H, Fahraeus T et al. Natural history of sinus node disease
39. Spearritt D. Torsades de pointes following cardioversion: case history and treated with atrial pacing in 213 patients: implications for selection of stimu-
literature review. Aust Crit Care 2003; 16(4): 144–9. lation mode. J Am Coll Cardiol 1992; 20: 633–9.
40. Dennis MJ. ECG criteria to differentiate pulmonary artery catheter irritation 66. Wilkoff BL, Cook JR, Epstein AE et al. Dual chamber pacing or ventricular
from other proarrhythmic influences as the cause of ventricular arrhythmias. backup pacing in patients with an implantable defribrillator: The Dual
[abstract]. Am Coll Cardiol 2002; 39(9)[SupplB]: 2B. Chamber and VVI Implantable Defibrillator (DAVID) trial. JAMA 2002; 288:
41. Di Marco JP, Gersh BJ, Opie LH. Antiarrhythmic drugs and strategies. In: 3115–23.
Opie LH, Gersh BJ, eds. Drugs for the heart, 6th edn. Philadelphia: Elsevier 67. Dennis MJ, Sparks PB. Pacemaker mediated tachycardia as a complication
Saunders; 2005. of the autointrinsic conduction search function. PACE 2004; 27(6Pt1):
42. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA et al. Cardiac resyn- 824–6.
chronization therapy with or without an implantable defibrillator in 68. Finkelmeier BA. Cardiothoracic surgical nursing, 2nd edn. Philadelphia:
advanced chronic heart failure. New Engl J Med 2004; 350: 2140–50. Lippincott, Williams & Wilkins; 2000.
43. Task Force of the Working Group on Arrhythmias of the European Society 69. Elmi F, Tullo N, Khalighi K. Natural history and predictors of temporary
of Cardiology. The Sicilian gambit: a new approach to the classification of epicardial pacemaker wire function in patients after open heart surgery.
antiarrhythmic drugs based on their actions on arrhythmogenic mecha- Cardiology 2002: 98(4): 175–80.
nisms. Circulation 1991; 84(4): 1831–51. 70. Jacobson C, Gerity D. Pacemakers and implantable defibrillators. In: Woods
44. Kuhlkamp V, Mermi J, Mewis C, Seipel L. Efficacy and proarrhythmia with S, Froelicher E, Underhill Motzer S, eds. Cardiac nursing, 5th edn. Philadel-
the use of d,l-sotalol for sustained ventricular tachyarrhythmias. J Cardiovasc phia: Lippincott, Williams & Wilkins; 2005.
Pharmacol 1997; 29(3): 373–81. 71. Chen LK, Teerlink JR, Goldschlager N. Pacing emergencies. In Brown DL, ed.
45. Australian Resuscitation Council. Medications in adult cardiac arrest: Revised Cardiac intensive care. Philadelphia: WB Saunders; 1998.
Policy Statement PS 11.4. Melbourne: Australian Resuscitation Council; 2002. 72. Lamas GA, Lee KL, Sweeney MO et al. for the Mode Selection Trial in Sinus-
46. Piccini P, Berger J, O’Connor C. Amiodarone for the prevention of sudden Node Dysfunction. Ventricular pacing or dual-chamber pacing for sinus
cardiac death: a meta-analysis of randomized controlled trials. Europ Heart node dysfunction. N Engl J Med 2002; 346: 1854–62.
J 2009; 30(10): 1245–53. 73. Mond HG, Hikkock RJ, Stevenson IH et al. The right ventricular outflow
47. Connolly S, Dorian P, Roberts R, Gent M, Bailin S, Fain E, Thorpe K et al. tract: The road to septal pacing. Pacing Clin Electrophysiology 2007;30:
Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for 482–91.
prevention of shocks from implantable cardioverter defibrillators: the OPTIC 74. Bakker P, Meijburg H, De Vries JW et al. Biventricular pacing in end-stage
Study: a randomized trial. JAMA 2006; 295: 165–71. heart failure improves functional capacity and left ventricular function.
48. Ahmad K, Dorian, P. Drug induced QT prolongation and proarrhythmia: an J Interv Cardiol 2000; 3: 395–404.
inevitable link? Europace 2007, iv16–iv22. 75. Hawkins NM, Petrie MC, MacDonald MR et al. Selecting patients for cardiac
49. Sadowski ZP et al. Multicentre randomized trial and systematic overview of resynchronization therapy: electrical or mechanical dyssynchrony? Eur Heart
lidocaine in acute myocardial infarction. Am Heart J 1999; 137: 792–8. J 2006; 27: 1270–81.
50. European Society of Cardiology. Guidelines for cardiac pacing and cardiac 76. Linde C, Leclerq C, Rex S et al. Long-term benefits of biventricular pacing in
resynchronization therapy. Europace 2007; 9, 959–98. congestive heart failure: results from the MUSTIC study. J Am Coll Cardiol
51. Mattingly E. AANA Journal course: update for nurse anesthetists – 2002; 40: 433–40.
arrhythmia management devices and electromagnetic interference. AANA J 77. Cleland JGF, Subert JC, Erdmann E et al. Longer-term effects of cardiac
2005; 73(2): 129–36. resynchronization therapy on mortality in heart failure [The Cardiac
52. Swerdlow CD, Gillberg JM, Olson WH. Sensing and detection. In: Ellenbo- Resynchronisation-Heart Failure (CARE-HF) trial extension phase]. Eur Heart
gen KA, Kay GN, Lau CP et al., eds. Clinical cardiac pacing, defibrillation, and J 2006; 27: 1928–32.
resynchronization therapy, 3rd edn. Philadelphia. Elsevier Saunders; 2007. 78. Auricchio A, Stellbrink C, Sack S et al. Pacing Therapies in Congestive Heart
53. Hayes DL, Friedman PA. Cardiac pacing, defibrillation and resynchronization, Failure (PATH-CHF) Study Group. Long-term clinical effect of hamodynami-
2nd edn. Singapore: Wiley-Blackwell; 2008. cally optimized cardiac resynchronisation therapy in patients with heart
54. Laczika K, Thalhammer F, Locker G et al. Safe and efficient emergency trans- failure and ventricular conduction delay. J Am Coll Cardiol 2002; 39:
venous ventricular pacing via the right supraclavicular route. Anesth Analg 2026–33.
2000; 90(4): 784–9. 79. Young JB, Abraham WT, Smithe AL et al. Combined cardiac resynchroniza-
55. Kay GN, Shepard RB. Cardiac electrical stimulation. In Ellenbogen KA, Kay tion and implantable cardioverter defibrillation in advanced chronic heart
GN, Lau CP et al., eds. Clinical cardiac pacing, defibrillation, and resynchroniza- failure: the MIRACLE ICD trial. JAMA 2003; 289: 2685–94.
tion therapy, 3rd edn. Philadelphia. Elsevier Saunders; 2007. 80. Bristow MR, Saxon LA, Boehmer J et al. Comparison of Medical Therapy,
56. Bernstein AD, Camm AJ, Fletcher RD et al. The NASPE/BPEG generic Pacing, Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac
pacemaker code for antibradyarrhythmic and adaptive rate pacing and resynchronization therapy with or without an implantable defibrillator in
antitachyarrhythmic devices. PACE 1987; 10: 794–99. advanced chronic heart failure. N Engl J Med 2004; 350: 2140–50.
57. Sgarbossa EB, Pinski SL, Gates KB et al. Early diagnosis of acute myocardial 81. Verrnooy K, Verbeek XAAM, Peschar M et al. Left bundle branch block
infarction in the presence of ventricular paced rhythm. Am J Cardiol 1996; induces ventricular remodelling and functional septal hypoperfusion. Eur
77(5): 423–44. Heart J 2005; 26: 91–8.
58. Schuchert A, Frese J, Stammwitz E et al. Low settings of the ventricular pacing 82. Sundell J, Engblom E, Koistinen J et al. The effects of cardiac resynchroniza-
output in patients dependent on a pacemaker: are they really safe? Am Heart tion therapy on left ventricular function, myocardial energetics and meta-
J 2002; 143(6): 1009–11. bolic reserve in patients with dilated cardiomyopathy and heart failure. J Am
59. Ellenbogen KA, Wood MA. Cardiac Pacing and ICDs, 4th edn. Oxford: Black- Coll Cardiol 2004; 43: 1027–33.
well Publishing; 2005. 83. Peichl P, Kautzner J, Cihak R et al. The spectrum of inter- and intraventricular
60. Tommaso C, Belic N, Brandfonbrener M. Asynchronous ventricular pacing: conduction abnormalities in patients eligible for cardiac resynchronization
a rare cause of ventricular tachycardia. PACE 1982; 5(4): 561–3. therapy. Pacing Clin Electrophysiol 2004; 27(8): 1105–12.
61. Gimbel JR, Bailey SM, Tchou PJ et al. Strategies for the safe magnetic reso- 84. Alonso C, Leclercq C, Victor F et al. Electrocardiographic predictive factors
nance imaging of pacemaker-dependant patients. PACE 2005; 28(10): of long-term clinical improvement with multisite biventricular pacing in
1041–6. advanced heart failure. Am J Cardiol 1998; 84: 1417–21.
62. Hayes DL, Zipes DP. Cardiac pacemakers and cardioverter-defibrillators. In 85. Abraham WT, Fisher WG, Smith AL et al. MIRACLE Study Group. Multicenter
Braunwald E, Dipes DP, Libby P, eds. Heart disease: a textbook of cardiovascular InSync Randomized Clinical Evaluation: Cardiac resynchronization in
medicine, 6th edn. Philadelphia: WB Saunders; 2001. chronic heart failure. N Engl J Med 2002; 346: 1845–53.
63. Vardas PE, Auricchio A, Blanc JJ et al. Guidelines for cardiac pacing and 86. Daubert JC. Atrial fibrillation and heart failure: a mutually noxious associa-
cardiac resynchronization therapy. The task force for cardiac pacing and tion. Europace 2004; 5: S1–S4.
cardiac resynchronization therapy of the European Society of Cardiology. 87. Meine TJ, An intracardiac EGM method for VV optimization during cardiac
Europace 2007; 9: 959–98. resynchronization therapy. Heart Rhythm J 2006; 3: AB30–35.
64. Kristensen L, Nielsen JC, Pedersen AK, et al. AV block and changes in pacing 88. Kenny T. The nuts and bolts of cardiac resynchronization therapy. Massachusetts:
mode during long-term follow-up of 399 consecutive patients with sick sinus Blackwell Futura; 2007.